We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$395M
AUM Growth
-$62.2M
Cap. Flow
-$70.5M
Cap. Flow %
-17.83%
Top 10 Hldgs %
40.77%
Holding
93
New
11
Increased
18
Reduced
29
Closed
19

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$8.57M
2
IMUX icon
Immunic
IMUX
+$5.02M
3
AMGN icon
Amgen
AMGN
+$4.6M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$4.28M
5
FULC icon
Fulcrum Therapeutics
FULC
+$3.65M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$18M
2
CRL icon
Charles River Laboratories
CRL
+$11.3M
3
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
+$7.96M
4
XLRN
Acceleron Pharma
XLRN
+$7.54M
5
NVRO
NEVRO CORP.
NVRO
+$5.93M

Sector Composition

Rank Sector Weight
1 Healthcare 97.83%
2 Industrials 0.81%
3 Technology 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOCL
76
EDAP TMS S.A.
FOCL
$178M
– –
-346,926
Closed -$2.46M
FBRX icon
77
Forte Biosciences
FBRX
$1.57B
– –
-1,256
Closed -$1.06M
INFU icon
78
InfuSystem Holdings
INFU
$244M
– –
-251,567
Closed -$5.23M
ISRG icon
79
Intuitive Surgical
ISRG
$142B
– –
-58,839
Closed -$18M
KPRX icon
80
Kiora Pharmaceuticals
KPRX
$11.7M
– –
-210
Closed -$275K
NTLA icon
81
Intellia Therapeutics
NTLA
$1.69B
– –
-7,500
Closed -$1.21M
PTGX icon
82
Protagonist Therapeutics
PTGX
$9.84B
– –
-130,000
Closed -$5.83M
WHWK
83
Whitehawk Therapeutics
WHWK
$269M
– –
-23,597
Closed -$598K
NVRO
84
DELISTED
NEVRO CORP.
NVRO
– –
-35,792
Closed -$5.93M
ASLN
85
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-5,647
Closed -$745K
BCEL
86
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-100,628
Closed -$857K
AMAM
87
DELISTED
Ambrx Biopharma Inc
AMAM
– –
-15,000
Closed -$294K
SPNE
88
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
– –
-225,000
Closed -$4.62M
TLMD
89
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
– –
-208,121
Closed -$1.18M
ITMR
90
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
– –
-338,001
Closed -$7.96M
XLRN
91
DELISTED
Acceleron Pharma
XLRN
– –
-60,074
Closed -$7.54M
TRIL
92
DELISTED
Trillium Therapeutics Inc.
TRIL
– –
-211,385
Closed -$2.05M
KDMN
93
DELISTED
Kadmon Holdings, Inc.
KDMN
– –
-501,740
Closed -$1.94M
1 2 3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Parkman Healthcare Partners held 93 positions worth $395M, down 14% from $457M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Parkman Healthcare Partners withdrew a net $70.5M in Q3 2021, closing 19 positions and reducing 29 holdings. Its most notable exit was Intuitive Surgical, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 96% a quarter earlier, followed by Industrials and Technology.

Against the trend, Parkman Healthcare Partners opened a new position in AbbVie worth $8.09M.

  • Parkman Healthcare Partners's largest Q3 2021 buy was AbbVie: 75,000 shares worth $8.09M.
  • Parkman Healthcare Partners added most to Immunic in Q3 2021, an estimated $5.02M increase.
  • Parkman Healthcare Partners's biggest Q3 2021 reduction was Charles River Laboratories, cutting an estimated $11.3M.
  • Parkman Healthcare Partners fully exited Intuitive Surgical in Q3 2021, selling an estimated $18M.
  • Parkman Healthcare Partners's ten largest holdings make up 41% of its $395M portfolio in Q3 2021.
  • Parkman Healthcare Partners opened 11 new positions and closed 19 in Q3 2021.
  • Parkman Healthcare Partners's portfolio value fell 14% quarter-over-quarter to $395M.

Based on Parkman Healthcare Partners's 13F filing for Q3 2021, filed 12 Nov 2021.